<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Lyme borreliosis (LB) is a multisystem infectious disease abundant in the northern countries of the world and is caused by <italic>Borrelia</italic> species. Vaccination against LB is an effective way to prevent and reduce the number of diseases in endemic areas. Several vaccines have been developed and tested in the past, but no human LB vaccine is currently available on the market. This review aims to uncover and delineate various strategies and diverse technological approaches related to vaccine production. Furthermore, we characterize already tested vaccines, possibilities for their future development, and reasons for their failure.</p>
</abstract>

Lyme borreliosis (LB) is a multisystem infectious disease abundant in the northern countries of the world and is caused by Borrelia species. Vaccination against LB is an effective way to prevent and reduce the number of diseases in endemic areas. Several vaccines have been developed and tested in the past, but no human LB vaccine is currently available on the market. This review aims to uncover and delineate various strategies and diverse technological approaches related to vaccine production. Furthermore, we characterize already tested vaccines, possibilities for their future development, and reasons for their failure.

Vaccines for Lyme Borreliosis: Facts and Challenges

Pavol Jozef Safarik University in Košice

Laboratory of biomedical microbiology and immunology

University of Veterinary Medicine and Pharmacy

Folia Veterinaria

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"Vaccines for Lyme Borreliosis: Facts and Challenges"}

Lyme borreliosis (LB) is a multisystem infectious disease abundant in the northern countries of the world and is caused by Borrelia species. Vaccination...

Vaccines for Lyme Borreliosis: Facts and Challenges

Online veröffentlicht: 31. März 2022

Seitenbereich: 49 - 59

Eingereicht: 15. Dez. 2021

Akzeptiert: 18. Feb. 2022

DOI: https://doi.org/10.2478/fv-2022-0006

Schlüsselwörter
LB prevention, Lyme borreliosis, vaccination options

© 2022 S. Bodnárová et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Vaccines for Lyme Borreliosis: Facts and Challenges

Online veröffentlicht: 31. März 2022

Seitenbereich: 49 - 59

Eingereicht: 15. Dez. 2021

Akzeptiert: 18. Feb. 2022

DOI: https://doi.org/10.2478/fv-2022-0006

SchlüsselwörterLB prevention, Lyme borreliosis, vaccination options

© 2022 S. Bodnárová et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Schlüsselwörter
LB prevention, Lyme borreliosis, vaccination options